MedPath

Effect of eye exercises on treating eye movement problems in individuals with Parkinson’s disease

Recruiting
Conditions
Other specified disorders of binocular movement,
Registration Number
CTRI/2021/07/034798
Lead Sponsor
Judy Jose
Brief Summary

This research aims to study the effect of vision therapy on oculomotor functions and vision-related quality of life in individuals with Parkinson’s disease. The main objectives of this study include (1) To estimate the oculomotor functions associated with Parkinson’s disease, (2) To find the effectiveness of vision therapy on oculomotor functions in individuals with Parkinson’s disease, (3) To assess vision related quality of life in individuals with Parkinson’s disease before and after vision therapy.

This study hypothesizes that there will be an improvement in oculomotor functions in individuals with Parkinson’s disease after a period of vision therapy and thereby an improvement in their vision-related quality of life.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
75
Inclusion Criteria

Individuals with Idiopathic Parkinson’s disease under regular medication who are having oculomotor dysfunction Individuals whose best-corrected distance visual acuity not less than 6/18 and near acuity not less than N24.

Exclusion Criteria

Subjects being one-eyed Subjects who are not able to comprehend and respond to the instruction given due to reduced visual acuity or hearing impairment Subjects with severe cognitive problems/ dementia Subjects who are already on any kind of eye exercises.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ï‚· CISS score1st week and 12th week
ï‚· VFQ-25 score1st week and 12th week
ï‚· Fixation stability1st week and 12th week
ï‚· Reaction time, Peak velocity, Acceleration and gain of saccade1st week and 12th week
ï‚· Pursuit gain1st week and 12th week
ï‚· Phoria measured in degrees1st week and 12th week
ï‚· NPC in millimetres1st week and 12th week
ï‚· PFV in prism dioptres1st week and 12th week
Secondary Outcome Measures
NameTimeMethod
1. CISS score2. VFQ-25 score

Trial Locations

Locations (1)

Neurology OPD

🇮🇳

Udupi, KARNATAKA, India

Neurology OPD
🇮🇳Udupi, KARNATAKA, India
Judy Jose
Principal investigator
09061699857
judy.jose@manipal.edu

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.